TC BioPharm (Holdings) plc financial data

Symbol
TCBP, TCBPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Maxim 1, 2 Parklands Way, Holytown, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
TC BioPharm (Holdings) Ltd (to 12/23/2021)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.9M shares
Common Stock, Shares, Outstanding 63.9M shares
Entity Public Float 3.1M USD
Common Stock, Value, Issued 6.39K GBP
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +1369%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +1369%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.3M GBP -32.8%
General and Administrative Expense 2.14M GBP -3.98%
Operating Income (Loss) -3.44M GBP +17.4%
Nonoperating Income (Expense) 3.13M GBP
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.43M GBP -232%
Income Tax Expense (Benefit) -111K GBP +72.3%
Net Income (Loss) Attributable to Parent -3.32M GBP -423%
Earnings Per Share, Basic -0.11 GBP/shares +64.5%
Earnings Per Share, Diluted -0.11 GBP/shares +64.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 981K GBP
Assets, Current 4.2M GBP
Property, Plant and Equipment, Net 1.16M GBP
Operating Lease, Right-of-Use Asset 1.29M GBP
Intangible Assets, Net (Excluding Goodwill) 609K GBP
Assets 7.26M GBP
Accounts Payable, Current 1.93M GBP
Accrued Liabilities, Current 1.01M GBP
Liabilities, Current 4.76M GBP
Operating Lease, Liability, Noncurrent 1.42M GBP
Liabilities 6.18M GBP
Retained Earnings (Accumulated Deficit) -42.2M GBP
Stockholders' Equity Attributable to Parent 1.08M GBP -3.24%
Liabilities and Equity 7.26M GBP

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.41M GBP +17.3%
Net Cash Provided by (Used in) Financing Activities 933K GBP -76.4%
Net Cash Provided by (Used in) Investing Activities -5.62K GBP +96.1%
Common Stock, Shares Authorized 63.9M shares
Common Stock, Shares, Issued 63.9M shares
Common Stock, Par or Stated Value Per Share 0 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.48M GBP -265%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 981K GBP -82.8%
Deferred Tax Assets, Valuation Allowance 4.45M GBP -7.44%
Deferred Tax Assets, Gross 4.45M GBP -7.44%
Operating Lease, Liability 1.73M GBP
Depreciation 115K GBP -32.2%
Payments to Acquire Property, Plant, and Equipment 120K GBP
Property, Plant and Equipment, Gross 5.43M GBP
Operating Lease, Liability, Current 308K GBP
Lessee, Operating Lease, Liability, to be Paid, Year Two 447K GBP
Lessee, Operating Lease, Liability, to be Paid, Year One 447K GBP
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 434K GBP
Lessee, Operating Lease, Liability, to be Paid, Year Three 447K GBP
Lessee, Operating Lease, Liability, to be Paid, Year Four 447K GBP
Operating Lease, Payments 112K GBP 0%
Additional Paid in Capital 42.8M GBP
Amortization of Intangible Assets 12.3K GBP +3.9%